Optiver Holding B.V. Terns Pharmaceuticals, Inc. Transaction History
Optiver Holding B.V.
- $6 Billion
- Q3 2025
A detailed history of Optiver Holding B.V. transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Optiver Holding B.V. holds 456 shares of TERN stock, worth $9,384. This represents 0.0% of its overall portfolio holdings.
Number of Shares
456Holding current value
$9,384% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TERN
# of Institutions
138Shares Held
85.2MCall Options Held
173KPut Options Held
89.5K-
Soleus Capital Management, L.P. Greenwich, CT8.17MShares$168 Million2.36% of portfolio
-
Orbimed Advisors LLC San Diego, CA7.56MShares$156 Million1.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.5MShares$154 Million0.99% of portfolio
-
Morgan Stanley New York, NY7.25MShares$149 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA6.9MShares$142 Million5.45% of portfolio
About Terns Pharmaceuticals, Inc.
- Ticker TERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,613,800
- Market Cap $774M
- Description
- Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...